For 0 3 0 3 O
those 4 9 4 9 O
patients 10 18 10 18 O
actively 19 27 19 27 O
receiving 28 37 28 37 O
checkpoint 38 48 38 48 B-treatment
inhibitor 49 58 49 58 I-treatment
immune 59 65 59 65 I-treatment
therapy 66 73 66 73 I-treatment
the 74 77 74 77 O
duration 78 86 78 86 O
of 87 89 87 89 O
immune 90 96 90 96 O
therapy 97 104 97 104 O
at 105 107 105 107 O
the 108 111 108 111 O
time 112 116 112 116 O
of 117 119 117 119 O
enrollment 120 130 120 130 O
must 131 135 131 135 O
be 136 138 136 138 O
4 139 140 139 140 B-upper_bound
months 141 147 141 147 I-upper_bound
or 148 150 148 150 O
less 151 155 151 155 O

HIV 0 3 156 159 B-chronic_disease
/ 3 4 159 160 O
AIDS 4 8 160 164 B-chronic_disease

History 0 7 165 172 O
of 8 10 173 175 O
prior 11 16 176 181 B-treatment
cytotoxic 17 26 182 191 I-treatment
chemotherapy 27 39 192 204 I-treatment
( 40 41 205 206 O
with 41 45 206 210 O
or 46 48 211 213 O
without 49 56 214 221 O
concomitant 57 68 222 233 O
radiation 69 78 234 243 B-treatment
therapy 79 86 244 251 I-treatment
) 86 87 251 252 O
with 88 92 253 257 O
subsequent 93 103 258 268 O
distant 104 111 269 276 O
( 112 113 277 278 O
metastatic 113 123 278 288 B-cancer
) 123 124 288 289 O
disease 125 132 290 297 O
relapse 133 140 298 305 O
, 140 141 305 306 O
or 142 144 307 309 O
progression 145 156 310 321 O
of 157 159 322 324 O
disease 160 167 325 332 O
while 168 173 333 338 O
on 174 176 339 341 O
chemotherapy 177 189 342 354 O

Measurable 0 10 355 365 O
disease 11 18 366 373 O
of 19 21 374 376 O
at 22 24 377 379 O
least 25 30 380 385 O
1.5 31 34 386 389 B-lower_bound
cm 35 37 390 392 I-lower_bound
in 38 40 393 395 O
greatest 41 49 396 404 O
dimension 50 59 405 414 O
at 60 62 415 417 O
least 63 68 418 423 O
2 69 70 424 425 B-lower_bound
non 71 74 426 429 O
- 74 75 429 430 O
irradiated 75 85 430 440 O
sites 86 91 441 446 O

Participant 0 11 447 458 O
must 12 16 459 463 O
be 17 19 464 466 O
planned 20 27 467 474 O
to 28 30 475 477 O
receive 31 38 478 485 O
( 39 40 486 487 O
or 40 42 487 489 O
actively 43 51 490 498 O
receiving 52 61 499 508 O
) 61 62 508 509 O
standard 63 71 510 518 O
of 72 74 519 521 O
care 75 79 522 526 O
checkpoint 80 90 527 537 O
inhibitor 91 100 538 547 O
immune 101 107 548 554 B-treatment
therapy 108 115 555 562 I-treatment

Stage 0 5 563 568 B-cancer
IV 6 8 569 571 I-cancer
metastatic 9 19 572 582 I-cancer
Non 20 23 583 586 I-cancer
Small 24 29 587 592 I-cancer
Cell 30 34 593 597 I-cancer
Lung 35 39 598 602 I-cancer
Cancer 40 46 603 609 I-cancer

Uncontrolled 0 12 610 622 O
intercurrent 13 25 623 635 B-chronic_disease
illness 26 33 636 643 I-chronic_disease

Uncontrolled 0 12 644 656 O
or 13 15 657 659 O
untreated 16 25 660 669 O
active 26 32 670 676 O
brain 33 38 677 682 B-cancer
metastases 39 49 683 693 I-cancer
/ 49 50 693 694 B-chronic_disease
CNS 50 53 694 697 O
disease 54 61 698 705 I-chronic_disease

cardiac 0 7 706 713 B-chronic_disease
arrhythmia 8 18 714 724 I-chronic_disease

hepatitis 0 9 725 734 B-chronic_disease
B 10 11 735 736 I-chronic_disease
or 12 14 737 739 I-chronic_disease
C 15 16 740 741 I-chronic_disease

lymph 0 5 742 747 O
nodes 6 11 748 753 O
, 11 12 753 754 O
in 13 15 755 757 O
which 16 21 758 763 O
the 22 25 764 767 O
short 26 31 768 773 O
- 31 32 773 774 O
axis 32 36 774 778 O
dimension 37 46 779 788 O
must 47 51 789 793 O
be 52 54 794 796 O
at 55 57 797 799 O
least 58 63 800 805 O
1.5 64 67 806 809 B-lower_bound
cm 67 69 809 811 I-lower_bound

ongoing 0 7 812 819 O
or 8 10 820 822 O
active 11 17 823 829 B-chronic_disease
infection 18 27 830 839 I-chronic_disease

primary 0 7 840 847 B-chronic_disease
immunodeficiency 8 24 848 864 I-chronic_disease
syndrome 25 33 865 873 I-chronic_disease

symptomatic 0 11 874 885 O
congestive 12 22 886 896 B-chronic_disease
heart 23 28 897 902 I-chronic_disease
failure 29 36 903 910 I-chronic_disease

unstable 0 8 911 919 B-chronic_disease
angina 9 15 920 926 I-chronic_disease
pectoris 16 24 927 935 I-chronic_disease

